Literature DB >> 1896634

Development of techniques to analyse the formation of HIV provirus in primary human macrophages.

M Collin1, W James, S Gordon.   

Abstract

The formation of provirus is an important early event in the life cycle of a retrovirus. We describe a system using PCR for the analysis of this process in primary human macrophages infected in vitro with HIV. We show that products of the first template switch can be detected within 8 h after infection at low multiplicity. The methods described provide a rapid assay of infection with HIV and can be applied in the investigation of a number of aspects of HIV replication in macrophages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1896634     DOI: 10.1016/0923-2516(91)90045-5

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  11 in total

1.  Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.

Authors:  P Greenhead; P Hayes; P S Watts; K G Laing; G E Griffin; R J Shattock
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.

Authors:  S Le Borgne; M Février; C Callebaut; S P Lee; Y Rivière
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro.

Authors:  P Crisell; S Thompson; W James
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

4.  Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.

Authors:  P M Cannon; W Wilson; E Byles; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Authors:  P B Fischer; M Collin; G B Karlsson; W James; T D Butters; S J Davis; S Gordon; R A Dwek; F M Platt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes.

Authors:  S Sonza; A Maerz; N Deacon; J Meanger; J Mills; S Crowe
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection.

Authors:  A D Leavitt; G Robles; N Alesandro; H E Varmus
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.

Authors:  P Sova; D J Volsky
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  HIV-1 induces tumour necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection.

Authors:  G Herbein; S Keshav; M Collin; L J Montaner; S Gordon
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

10.  A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection.

Authors:  J H Simon; C Somoza; G A Schockmel; M Collin; S J Davis; A F Williams; W James
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.